Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned

Area of Science:

• Neurology
• Infectious Diseases
• Critical Care Medicine

Background:

• The Milwaukee protocol is a treatment regimen suggested for rabies encephalitis.
• Its efficacy is often cited in anecdotal survival cases, but scientific validation is lacking.
• Rabies encephalitis is a severe neurological disease with a high mortality rate.

Purpose of the Study:

• To critically review the scientific literature supporting the therapeutic interventions recommended in the Milwaukee protocol.
• To evaluate the evidence for excitotoxicity and cerebral vasospasm in rabies encephalitis.
• To assess the validity of therapies such as therapeutic coma, ketamine, and amantadine in treating rabies and other viral encephalitides.

Main Methods:

• Systematic literature review focusing on rabies encephalitis and its treatment.
• Analysis of studies investigating the roles of excitotoxicity and cerebral vasospasm in viral encephalitis.
• Evaluation of evidence for specific agents like ketamine and amantadine in the context of acute viral encephalitis.

Main Results:

• Current scientific literature does not support a significant role for excitotoxicity or cerebral vasospasm in rabies encephalitis.
• Evidence substantiating the efficacy of therapeutic coma, ketamine infusion, or amantadine in rabies or other acute viral encephalitides is absent.
• The therapeutic measures within the Milwaukee protocol lack scientific backing.

Conclusions:

• The Milwaukee protocol's recommendations are not supported by current scientific evidence.
• Serious concerns exist regarding the continued use of the Milwaukee protocol.
• Reconsideration of the Milwaukee protocol's components is urgently needed before any future application.